Sequential™ gains momentum in AI

The specialist in non-invasive genomic testing has announced the closing of its first funding round of $3.5 million (€3 million), led by Sparkfood and Corundum Systems Biology (CSB). This financing brings the total capital raised to $7.5 million (€6.5 million). The operation will support the development of an AI-driven discovery engine based on Sequential’s clinical data for the identification and development of new bioactive ingredients.